Physician profile
Rafik Dib
NPI 1902142722
$6,098.32
in general payments reported to CMS, 2019-2025
10 companies · $604 in 2025
The $604 reported for 2025 was more than what 84% of Periodontics providers received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2021: $280 · 2022: $1,428 · 2023: $2,385 · 2024: $1,208 · 2025: $604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,816 · Education: $381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,816.04 |
| Education | $381.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $4,835.24 | 2021-2025 | |
| Kulzer, LLC | $484.44 | 2024-2025 | |
| Biohorizons Implant Systems INC. | $188.10 | 2025 | Biohorizons Dental Implants |
| Implant Direct Sybron International LLC | $162.25 | 2019 | |
| Planmeca USA, INC. | $137.81 | 2025 | Planmeca Promax |
| Geistlich Pharma, North America, INC. | $121.44 | 2021 | |
| Solventum Corporation | $85.36 | 2025 | Clarity Aligners, 3m Filtek, 3m Clinpro |
| Henry Schein, INC. | $34.62 | 2024 | |
| Zimmer Biomet Holdings, INC. | $30.67 | 2019 | |
| Orapharma, A Division of Bausch Health US, LLC | $18.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafik Dib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.